Adeline Waltz|
Danielle Hutchinson assumed the role of associate client executive within our Benefits Consulting department upon joining the MJ team. In her role, Danielle collaborates with MJ clients to inform benefit strategies and provides support in the management and execution of the plan. Additionally, Danielle works with the analytics, wellness, compliance, communication, and client advocacy teams to execute client healthcare and benefits strategies and ensure a seamless client experience.
Prior to MJ, Danielle previously served as a client service manager at a global brokerage. In this role, Danielle worked with clients on their health and benefit plans. Her passion for superior client service paired with continuous process improvement make her an invaluable asset to both MJ and our clients.
Related Blogs
EBSA Updates National Employee Benefit Plan Enforcement Projects for 2026
DeAnn DeckThe Employee Benefits Security Administration (EBSA) announced updates to its national enforcement projects for fiscal year 2026. According to EBSA, these projects highlight areas ...
Read More
The Hard Market Is Shifting—Here’s What That Means for YOU
Adam AdlerFor years, organizations have been told the same thing at renewal: higher costs, fewer options, and little room to negotiate. Now, that message is ...
Read More
Employer Response to Pharma Shifts
Chris AntypasVolatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More
White House Launches TrumpRx, Unveils Drug Prices
DeAnn DeckOn Feb. 5, President Donald Trump announced the launch of TrumpRx.gov, a federally operated website to help individuals buy prescription medications at discounted cash ...
Read More
DOL Issues Updated Model Employer CHIP Notice
DeAnn DeckThe U.S. Department of Labor (DOL), through its Employee Benefits Security Administration (EBSA), has released a new model Employer CHIP Notice with information current ...
Read More
Prescription Drug Reporting (RxDC Report)
DeAnn DeckThe No Surprises Act (NSA), enacted as part of the Consolidated Appropriations Act, 2021 (CAA), includes transparency provisions requiring group health plans to report ...
Read More